{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:31:11Z","timestamp":1789594271363,"version":"build-2803163510"},"reference-count":74,"publisher":"Baishideng Publishing Group Inc.","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3748\/wjg.v21.i40.11273","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T10:26:52Z","timestamp":1446028012000},"page":"11273","source":"Crossref","is-referenced-by-count":50,"title":["Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease"],"prefix":"10.3748","volume":"21","author":[{"given":"Alicia C","family":"Mar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114660"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.013"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21667"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-87"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0105"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1980-8"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.035"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21706"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.523"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21800"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04570.x"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.208413"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20943"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.733"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Coates T, Wilson R, Patrick G, Andr&eacute; F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001;23:392-403.","DOI":"10.1016\/S0149-2918(01)80044-8"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004;10:677-692.","DOI":"10.1097\/00054725-200409000-00028"},{"key":"ref17","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55:1-33; quiz CE1-4."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00646.x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2008.07.013"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.79"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.009"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05110.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.557"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Banatvala JE, Van Damme P. Hepatitis B vaccine -- do we need boosters? J Viral Hepat 2003;10:1-6.","DOI":"10.1046\/j.1365-2893.2003.00400.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90530-5"},{"key":"ref26","unstructured":"Jafarzadeh A, Bagheri-Jamebozorgi M, Nemati M, Golsaz-Shirazi F, Shokri F. Eukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine. Iran J Allergy Asthma Immunol 2015;In press."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Chedid MG, Deulofeut H, Yunis DE, Lara-Marquez ML, Salazar M, Deulofeut R, Awdeh Z, Alper CA, Yunis EJ. Defect in Th1-like cells of nonresponders to hepatitis B vaccine. Hum Immunol 1997;58:42-51.","DOI":"10.1016\/S0198-8859(97)00209-7"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Shokrgozar MA, Shokri F. Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen. Immunology 2001;104:75-79.","DOI":"10.1046\/j.1365-2567.2001.01273.x"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2529"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Suzuki T, Yamauchi K, Kuwata T, Hayashi N. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders. J Gastroenterol Hepatol 2001;16:898-903.","DOI":"10.1046\/j.1440-1746.2001.02530.x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-7347.2011.11.003"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2005.apm_191.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-013-0219-0"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090971"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1545109710368721"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-0043-6"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.046"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/ng.717"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.","DOI":"10.1016\/S1386-6532(00)00125-6"},{"key":"ref40","unstructured":"Nowak Z, Karowicz-Bili\u0144ska A. [Human papilloma virus infection in pregnant women with normal pap-smears, HPV oncogenity and risk factors]. Ginekol Pol 2007;78:678-684."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641348\/6\/518"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281341b"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2008.00035.x"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000232632.86800.8c00006454-200609000-00008"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 2002;21:559-566.","DOI":"10.1016\/S1053-2498(01)00405-3"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704048"},{"key":"ref49","unstructured":"Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007;56:1-54."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.120"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077552"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000438024.10375.2d"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.928902"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.065"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Targonski PV, Poland GA. Pneumococcal vaccination in adults: recommendations, trends, and prospects. Cleve Clin J Med 2007;74:401-46, 401-46, 401-46.","DOI":"10.3949\/ccjm.74.6.401"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.030"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit139"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022020"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.048"},{"key":"ref60","unstructured":"Di Sabatino A, Carsetti R, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Tinozzi FP, Tinozzi S, Corazza GR. Immunoglobulin M memory B cell decrease in inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2004;8:199-203."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41939.x"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2014.8.1.24"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20374"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Salinas GF, De Rycke L, Barendregt B, Paramarta JE, Hreggvidstdottir H, Cantaert T, van der Burg M, Tak PP, Baeten D. Anti-TNF treatment blocks the induction of T cell-dependent humoral responses. Ann Rheum Dis 2013;72:1037-1043.","DOI":"10.1136\/annrheumdis-2011-201270"},{"key":"ref65","unstructured":"Brogan MD, Shanahan F, Oliver M, Stevens RH, Targan SR. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol 1987;24:69-74."},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Stevens R, Oliver M, Brogan M, Heiserodt J, Targan S. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn&rsquo;s disease and ulcerative colitis patients. Gastroenterology 1985;88:1860-1866.","DOI":"10.1016\/0016-5085(85)90011-3"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Nielsen HJ, Mortensen T, Holten-Andersen M, Br&uuml;nner N, S&oslash;rensen S, Rask-Madsen J. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol 2001;36:265-269.","DOI":"10.1080\/00365520118314"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20089"},{"key":"ref69","unstructured":"Marin M, G&uuml;ris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56:1-40."},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"ref71","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30; quiz CE2-4."},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, Saag KG, Baddley JW, Curtis JR. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012;308:43-49.","DOI":"10.1001\/jama.2012.7304"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20161"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75a.08046"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i40\/11273.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T02:02:15Z","timestamp":1567303335000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i40\/11273.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":74,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v21.i40.11273","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}